Lung Cancer Trials Ask AI to find trials
RecruitingNot applicableNCT06124508
Official study title

PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors

Study summary

The purpose of this study is to assess the awareness of eligibility of lung cancer screening in Hispanic/LatinX Head and Neck Cancer (HNC) survivors using a survey questionnaire; and to understand the barriers to screening using qualitative interviews.

Ask AI to explain this study
Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedLung Cancer Screening Education and Semi-Structured Interview

Plus 1 other study approaches.

Who it may be forHead and Neck Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Apr 28, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Miami

Study sponsor

01
Study overview

What this study is about

Purpose
Screening
Study type
Interventional
Phase
Not applicable
Sponsor
University of Miami
Interventions being studied
Behavioral: Lung Cancer Screening Education; Behavioral: Semi-Structured Interview; Behavioral: Standard of Care Lung Cancer Screening Program
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Participants must be able to understand, and sign informed consent form.
  • Age ≥ 18 years.
  • Participants must self-identify as Hispanic/LatinX.
  • Individuals must be head and neck cancer survivors (treated locally with surgery, radiation alone, or definitive chemoradiation ≥ 5 years earlier and have no signs/symptoms to suggest recurrence of disease).
  • Subjects that meet lung cancer (LC) screening eligibility according to United States Preventive Services Task Force (USPSTF21) and/or National Comprehensive Cancer Network (NCCN). For patients with a history of head and neck cancers, the NCCN recommends annual screening with low dose computerized tomography (LDCT) in those who have had a history of 20 pack years of smoking or more. USPSTF21 LC screening eligibility includes adults ages 50-80 that are current smoker or former smokers that quit within 15 years and have a 20 pack-year history or more of smoking.
Reasons someone may not be able to joinExclusion criteria
  • Individuals with pre-established diagnosis of lung cancer.
  • Participants with current diagnosis of any active malignancy.
  • Subjects that had undergone lung imaging within previous 3 years.
  • Pregnant or nursing mothers.
  • Individuals that received head and neck related treatment less than 5 years before screening.
  • Individuals with \< 20 pack year history of smoking.
  • Subjects with previous history of distant metastatic head and neck cancer.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of MiamiMiami, Florida

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 28, 2026. Always confirm current availability with the study team.

View original record ↗